Priser
Platform
Blog
Om os
Download
301075
Tibet Duorui Pharmaceutical Co
Shenzhen Stock Exchange
0

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I TIBET DUORUI PHARMACEUTICAL CO MED ENDAVU: Køb Tibet Duorui Pharmaceutical Co ($301075) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Tibet Duorui Pharmaceutical Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Om

Tibet Duorui Pharmaceutical Co., Ltd. is a specialized entity in the pharmaceutical industry, primarily focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company is renowned for its emphasis on traditional Chinese medicine, leveraging natural ingredients to create innovative healthcare solutions. A significant portion of its operations involves the production of herbal and botanical-based pharmaceuticals that are applied across various therapeutic areas, including wellness, chronic disease management, and preventive care. By aligning with the growing demand for alternative and complementary medicines, Tibet Duorui plays a pivotal role in promoting health and well-being, particularly within Asian markets well-versed in the efficacy of traditional practices. The company’s commitment to quality and authenticity positions it as a key player in the niche market of traditional pharmaceuticals, contributing to the preservation and advancement of ancient medicinal wisdom while integrating modern scientific approaches.

Information

Ticker301075
Land
Kina
Antal medarbejdere461
Hjemmesideduoruiyy.com
SektorSundhed
IndustriLægemiddelproducenter - Specialitet og generisk

Udbytter

1,68CNH
'18
1,87CNH
'19
1,97CNH
'20
2,42CNH
'21
3,68CNH
'22
0,13CNH
'24
Ex-udbytte-dato31. maj 2024
Udbytteafkast1,76%